MedTrace Logo

Establishing Muscle Impedance Parameters With Electrical Impedance Myography

NCT03633318 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2020-08-11

No results posted yet for this study

Summary

The primary aim of this study is to assess the changes in the impedance parameters of muscles in inclusion body myositis (IBM) through electrical impedance myography (EIM), an emerging non-invasive electrodiagnostic technology. Muscle impedance parameters can potentially serve as an objective biomarker reflecting disease progression and severity.

Conditions

  • IBM
  • Inclusion Body Myositis

Interventions

DEVICE

electrical impedance myography (EIM)

EIM is a measure of impedance. EIM is a measure of the obstruction of flow of current through the tissue. It is a completely painless assessment of muscle health.

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Bhaskar Roy, MBBS · Yale School of Medicine: Department of Neurology

  • Richard J Nowak, MD, MS · Yale School of Medicine: Department of Neurology

Eligibility

Min Age
46 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-19
Primary Completion
2019-06-30
Completion
2019-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03633318 on ClinicalTrials.gov